The National Institutes of Health dealt a stunning blow to the US scientific and medical research communities in February by trying to impose a 15% cap on grant recipients’ indirect costs. This includes reimbursements for “go forward expenses” on existing awards to institutions of higher education.
The cap could reduce indirect funding payments distributed to 149 US medical schools by as much as $3.3 billion, and the NIH itself estimates this move would shave $4 billion a year from payments for medical research by the agency.
A federal court in Massachusetts placed the cap under a temporary restraining order in ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.